Cardinal Capital Management - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cardinal Capital Management ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,002,222
+8.0%
11,188
+2.6%
0.20%
+9.1%
Q2 2023$928,197
+4.1%
10,902
+1.1%
0.19%
+1.1%
Q1 2023$891,963
+5.2%
10,779
-0.0%
0.18%
+2.8%
Q4 2022$847,847
+8.7%
10,780
+2.3%
0.18%
-2.7%
Q3 2022$780,000
+17.3%
10,542
+3.3%
0.18%
+21.7%
Q2 2022$665,000
+9.2%
10,205
+5.9%
0.15%
+23.6%
Q1 2022$609,000
+41.3%
9,637
+18.7%
0.12%
+44.7%
Q4 2021$431,000
-22.1%
8,121
+3.7%
0.08%
-29.2%
Q3 2021$553,000
+17.4%
7,828
+10.8%
0.12%
+21.2%
Q2 2021$471,000
-48.0%
7,067
-13.4%
0.10%
-50.5%
Q1 2021$905,000
-5.5%
8,156
+1.1%
0.20%
-11.9%
Q4 2020$958,000
+39.4%
8,068
+2.5%
0.23%
+20.1%
Q3 2020$687,000
+1.5%
7,872
+4.1%
0.19%
-3.1%
Q2 2020$677,000
-4.6%
7,561
+6.0%
0.20%
-17.0%
Q1 2020$710,000
-22.1%
7,130
-10.1%
0.24%
-0.8%
Q4 2019$911,000
-10.1%
7,927
-1.4%
0.24%
-15.4%
Q3 2019$1,013,000
+3.9%
8,036
-0.8%
0.28%
+1.1%
Q2 2019$975,000
+35.0%
8,102
-1.9%
0.28%
+34.5%
Q1 2019$722,000
-10.9%
8,260
+2.0%
0.21%
-22.8%
Q4 2018$810,000
-10.9%
8,100
+2.1%
0.27%
+3.9%
Q3 2018$909,000
+28.4%
7,937
+0.5%
0.26%
+20.1%
Q2 2018$708,000
+24.0%
7,898
+1.2%
0.21%
+19.6%
Q1 2018$571,000
-33.9%
7,807
-47.5%
0.18%
-31.4%
Q4 2017$864,000
+28.2%
14,879
-1.0%
0.26%
+22.5%
Q3 2017$674,000
+24.8%
15,029
+10.0%
0.21%
+19.0%
Q2 2017$540,000
+13.0%
13,666
+16.1%
0.18%
+3.5%
Q1 2017$478,000
+2.6%
11,773
+1.7%
0.17%
-2.3%
Q4 2016$466,000
+29.8%
11,580
+16.8%
0.18%
+25.5%
Q3 2016$359,000
+39.1%
9,916
+11.3%
0.14%
+34.3%
Q2 2016$258,000
-10.4%
8,906
+8.0%
0.10%
-13.2%
Q1 2016$288,000
+21.5%
8,247
+12.4%
0.12%
+9.0%
Q3 2015$237,000
-9.9%
7,337
+15.3%
0.11%
-3.5%
Q2 2015$263,000
+13.9%
6,366
+23.7%
0.12%
+17.3%
Q1 2015$231,0005,1470.10%
Other shareholders
HAEMONETICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders